Chronic migraine is not simply a headache condition that happens to occur frequently. It is a neurological disorder involving central sensitization of pain-processing pathways, and that distinction is why patients who have cycled through triptans, preventive medications, and CGRP inhibitors without finding lasting relief are not running out of options so much as running up against the limits of treatments that manage migraine episodes without addressing the neurological dysregulation driving them. For this patient population, IV ketamine represents a fundamentally different approach, one that acts on the central mechanism rather than the episodic symptom.
What Chronic Migraine Actually Is
Chronic migraine is defined as 15 or more headache days per month for at least three months, with at least eight of those days meeting the diagnostic criteria for migraine (National Institutes of Health). This designation separates it clinically from episodic migraine not just by frequency but by its underlying neurological features. Chronic migraine involves changes to the way the brain processes sensory information, including central sensitization, a state in which pain-processing pathways in the spinal cord and brain become hyperexcitable and amplify signals beyond what any peripheral input would warrant.
The significance of this is that chronic migraine has an ongoing neurological substrate, not simply a high rate of discrete headache events. This is why preventive medications that reduce the frequency of episodic attacks may provide partial benefit for some chronic migraine patients without fully resolving the neurological dysregulation driving the condition. At the level of chronic migraine, something has changed in how the nervous system itself processes sensory input, and that change does not resolve through the same mechanisms that manage individual attacks.
The quality-of-life impact of migraine at this frequency is substantial. Research documents that persistent pain significantly affects overall well-being, functioning, and daily life across multiple domains (National Institutes of Health). For patients whose migraines have taken over their schedules, their relationships, and their capacity to plan any day reliably, the need for treatment that addresses the underlying mechanism rather than just the episodes is not theoretical.
Why Standard Migraine Treatments Have Limits for Some Patients
The available treatments for chronic migraine fall into two broad categories: acute treatments that abort or reduce the severity of an individual attack, and preventive treatments that aim to reduce the frequency of future attacks. Acute treatments include triptans (serotonin receptor agonists that constrict blood vessels and interrupt pain signaling during a migraine attack), NSAIDs, and anti-nausea medications. Preventive treatments include beta blockers, anticonvulsants, tricyclic antidepressants, and, more recently, CGRP inhibitors (calcitonin gene-related peptide inhibitors, a class of medications that target a specific protein involved in migraine signaling).
Each of these approaches works for a meaningful proportion of patients. The challenge is that a significant subset of chronic migraine patients do not achieve adequate or lasting relief from any of them. For those patients, the remaining conventional options often include opioids, which are not recommended as long-term treatment for chronic headache and carry their own risks, and procedures such as nerve blocks or Botox, which may provide temporary relief without addressing the neurological sensitization driving the condition.
This is the gap that IV ketamine addresses. The same central sensitization mechanism that underlies chronic migraine also drives other chronic pain conditions — our detailed overview of central sensitization and chronic pain explains how the nervous system becomes the primary pain generator and why standard treatments fall short.
How IV Ketamine Targets the Neurological Root of Chronic Migraine
Ketamine is a non-competitive NMDA receptor antagonist, meaning it works by blocking the N-methyl-D-aspartate receptors that regulate synaptic excitability and play a central role in the induction and maintenance of central sensitization (National Institutes of Health). In the chronic migraine context, this mechanism targets the neurological amplification that distinguishes chronic from episodic migraine at its source, rather than managing individual attacks once they have already begun.
By interrupting the amplified pain signaling at the spinal cord and brainstem level, IV ketamine can reduce the baseline neurological hyperresponsiveness that makes patients with chronic migraine vulnerable to frequent, severe attacks. Many patients who complete an IV ketamine series for migraines report reductions in both the frequency and intensity of attacks following treatment. Results vary by individual, and the response to ketamine for migraine pain can build over weeks following the completion of the series rather than appearing immediately, which differs from the rapid mood effects seen in psychiatric applications.
This is not a treatment for managing an acute migraine episode. It is specifically relevant for patients with chronic or refractory migraine whose condition has reached the point where the standard treatment toolkit has not provided adequate long-term relief.
The Non-Opioid Distinction
The non-opioid framing in this blog’s title is deliberate. Opioids are frequently offered to chronic migraine patients whose standard treatments have failed, and they carry a specific risk in the headache context: medication overuse headache (sometimes called rebound headache), a pattern in which frequent opioid use can increase the frequency and intensity of migraine attacks over time, making the underlying condition harder to treat. The opioid pathway also operates through a different mechanism than NMDA receptor modulation and does not address the central sensitization that drives chronic migraine.
IV ketamine reaches a pain mechanism that opioids bypass entirely. It is not an opioid, it does not carry the overuse headache risk associated with opioid treatment, and it is administered in a controlled clinical setting with continuous monitoring rather than taken at home without oversight. For patients who have been offered opioids as the next step and are looking for an alternative that addresses the actual neurological driver of their condition, IV ketamine is that option. For patients who are already on opioids for migraine management, the consultation is where we review the full picture and discuss what a transition or adjunctive approach might look like.
What Treatment at Our Clinic Looks Like
At Ketamine Wellness Infusions PA, patients with chronic migraines are evaluated individually before treatment begins. We conduct our own psych evaluation on each patient. We coordinate with your existing care team throughout treatment. Our full overview of the pain disorders we treat provides additional context on the range of conditions we address through IV ketamine.
The pain treatment protocol at our clinic typically involves between three and ten infusions, with the specific number determined by your diagnosis, history, and response. Each session takes place in a calm, private room at our Bala Cynwyd clinic, supervised by Jill Gabay, CRNA, with more than 30 years of anesthesia experience. A responsible adult must drive you home following each session, and a safe ride can be arranged upon request for an additional charge.
Most insurance plans do not cover IV ketamine for chronic migraine, as it is an off-label application. We provide billing codes for potential out-of-network reimbursement requests and discuss the financial aspects of treatment during the consultation. Veterans receive a 20 percent discount and healthcare workers receive a 10 percent discount. We do not believe the cost question should be sidestepped, and we make a point of addressing it clearly before you commit to anything.
Frequently Asked Questions
Is IV ketamine appropriate for episodic migraine, or only chronic migraine? IV ketamine is most clinically relevant for chronic migraine, particularly in patients who have not achieved adequate relief from standard preventive and acute treatments. Patients with high-frequency episodic migraine that is trending toward the chronic threshold may also be candidates depending on their history and the degree of central sensitization involved. The consultation will evaluate whether IV ketamine is appropriate for your specific presentation.
How many infusions will I need for chronic migraine treatment? The pain protocol at our clinic involves between three and ten infusions, with the specific number determined by your diagnosis, history, and response. The response to ketamine for migraine may build over weeks following the series rather than appearing immediately after the first infusion, which differs from the pattern seen in mood disorder treatment. Results vary by individual and we discuss realistic expectations at the consultation.
Can IV ketamine be combined with my current migraine medications? In most cases, yes. Your current migraine medication list is reviewed at the consultation, and any adjustments needed to support the best possible response to ketamine are discussed before treatment begins. Any changes to your current regimen should be made in coordination with your neurologist or prescribing provider. We welcome direct communication with your specialist team.
Will IV ketamine stop my migraines permanently? IV ketamine is not a cure for chronic migraine, and we do not present it as one. The goal of treatment is meaningful reduction in migraine frequency and severity and improved quality of life. Some patients experience sustained benefit following their initial series. Others benefit from periodic maintenance infusions to preserve the effect over time. Your ongoing treatment plan is based on your actual clinical response. You can learn more at our migraine treatment page for Lower Merion Township.
Does insurance cover IV ketamine for migraines? Most insurance plans do not cover IV ketamine for chronic migraine, as it is administered off-label for this indication. We provide billing codes for potential out-of-network reimbursement requests and recommend contacting your carrier before beginning treatment. Our team discusses all financial options during the consultation.
Key Takeaways
- Chronic migraine is a neurological condition involving central sensitization of pain pathways, not simply frequent headaches. This distinction explains why standard migraine treatments provide incomplete relief for a meaningful proportion of patients.
- IV ketamine acts on NMDA receptors that regulate central pain sensitization, addressing the neurological mechanism driving chronic migraine rather than managing individual episodes after they begin.
- IV ketamine is a non-opioid option that does not carry the medication overuse headache risk associated with opioid treatment for migraine.
- The pain treatment protocol at Ketamine Wellness Infusions PA involves three to ten infusions. The migraine response may build over weeks following the series, differing from the rapid onset seen in mood disorder treatment.
- Results vary by individual. Every migraine patient at our clinic is evaluated individually and given an honest assessment of whether IV ketamine is the right fit for their history and presentation.
Chronic migraines that have stopped responding to standard treatment are not a dead end. For patients in Lower Merion Township and the greater Philadelphia area who have cycled through triptans, preventive medications, and CGRP inhibitors without finding lasting relief, IV ketamine offers a mechanism and a pathway that none of those treatments reach. At Ketamine Wellness Infusions PA, we give every patient a clear, honest assessment of whether that pathway makes sense for their situation. We encourage you to explore your options and discuss IV ketamine with your neurologist or headache specialist. Call us at (484) 434-8963 or schedule a consultation to get started.
References
- National Institutes of Health. Migraine Pathophysiology and Treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC9506374/
- National Institutes of Health. Ketamine for Chronic Pain: NMDA Receptor Mechanisms. https://www.ncbi.nlm.nih.gov/books/NBK539824/
- National Institutes of Health. Persistent Pain and Quality of Life. https://pubmed.ncbi.nlm.nih.gov/9669787/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. IV ketamine therapy for chronic migraine should only be pursued under the supervision of a licensed medical provider familiar with your full medical and headache history. Individual results vary. If you are experiencing a sudden severe headache unlike any you have had before, or any neurological symptoms requiring emergency evaluation, please go to your nearest emergency room or call 911.